The impact of peripheral arterial disease on patients with congestive heart failure

Amit N Keswani; Christopher J White

doi:10.1016/j.hfc.2013.10.006

The impact of peripheral arterial disease on patients with congestive heart failure

Heart Fail Clin. 2014 Apr;10(2):327-38. doi: 10.1016/j.hfc.2013.10.006.

Authors

Amit N Keswani¹, Christopher J White²

Affiliations

¹ Department of Cardiology, Ochsner Clinic Foundation, Ochsner Clinical School, University of Queensland, New Orleans, LA, USA.
² Department of Cardiology, Ochsner Clinic Foundation, Ochsner Clinical School, University of Queensland, New Orleans, LA, USA. Electronic address: cwhite@ochsner.org.

PMID: 24656109
DOI: 10.1016/j.hfc.2013.10.006

Abstract

Congestive heart failure (CHF) is a prevalent disease with many comorbidities and is associated with high health care expenditures. Peripheral arterial disease (PAD) is a known comorbidity of CHF and is associated with worse morbidity and mortality. CHF and PAD share risk factors, pathophysiology, treatment strategies, and prognostic features. We review the impact of PAD on patients with CHF using several studies to support PAD's influence on outcomes in CHF. Based on the evidence and current guidelines, patients with heart failure who are smokers, and those who have known coronary artery disease and/or diabetes should be screened for PAD.

Keywords: Congestive heart failure; Peripheral angioplasty; Peripheral arterial disease.

Publication types

Review

MeSH terms

Heart Failure / complications*
Heart Failure / physiopathology
Heart Failure / therapy
Humans
Peripheral Arterial Disease / complications*
Peripheral Arterial Disease / physiopathology
Peripheral Arterial Disease / therapy
Risk Factors